skip to primary navigationskip to content

11.02.19 Steve Jackson to receive the ARC Foundation's Léopold Griffuel Award

last modified Apr 11, 2019 09:48 AM
Steve Jackson wins prestigious cancer research award from the Fondation ARC pour la recherche sur le cancer

*UPDATE: Watch this film made by Fondation ARC and shown at the award ceremony on 10th April at the Salon de l’hôtel des Arts et Métiers in Paris, on Steve and his research (also featuring lab members Kate, Francisco, Harvey and Rebecca). *


The Fondation ARC Léopold Griffuel Award a prestigious European cancer research prize that has been awarded annually since 1970.

Fondation ARC is the largest French foundation dedicated entirely to cancer research, and is funded by public donations. Their mission is to support research in the fight to eradicate cancers, with an ambitious goal "to cure 2 cancers out of 3 by 2025".

The award winners are scientists and physicians who have made an important contribution to better understand, diagnose, cure and prevent cancers. The award was created according to the will of the late Mrs Griffuel by bequest, in honour and memory of her late husband, Mr. Léopold Griffuel.

Fondation ARC has announced that two outstanding scientists will receive awards, including prizes of Euro 150,000, in 2019:

In Basic Research, Prof. Laurence Zitvogel (UMR Inserm) for her research in immunology, which improved the understanding of the biological mechanisms of the anticancer immune response and immunotherapies. Her discoveries have changed the way the immune system is understood in relation to cancer treatment.

In Translational and Clinical Research, Prof. Steve Jackson (Wellcome/ Cancer Research UK Gurdon Institute) for his work on DNA damage repair and his role in the development of medicines such as PARP1 and 2 inhibitors, currently used for cancer treatment.


Prof Jackson said: "It is a great privilege and honour to receive this important award, which recognises my colleagues and I successfully translating our ground-breaking basic science towards a new cancer therapy that is already extending and enhancing the lives of many cancer sufferers worldwide.

"I am pleased that 80% of the award will be used to fund further research in my laboratory defining fundamental mechanisms of DNA repair and exploring how this knowledge might yield new opportunities for alleviating cancer."


Institute reopening

The Gurdon Institute reopened on Monday 15th June. Many staff will continue to work from home, and all staff may be contacted by email.

Studying development to understand disease

The Gurdon Institute is funded by Wellcome and Cancer Research UK to study the biology of development, and how normal growth and maintenance go wrong in cancer and other diseases.

combinedLogo x3 trans2018


Share this